[Research Report] The clinical trial supplies market was valued at US$ 1,867.44 million in 2019 and is expected to grow at a CAGR of 7.4% from 2020 to 2027 to reach US$ 3,298.91 million by 2027.
Market Insights and Analyst View:
The clinical trial is an investigation study that defines whether a medical approach, therapy, or device is effective, safe, and useful for human applications. These studies help to find which therapeutic approaches experiment is best for certain diseases. Clinical trial supplies management is necessary for evading overproduction, oversupply, and inventory expiration. With the increasing costs of drug discovery, clinical trial supplies are obtaining more importance. In addition, implementing more stringent handling requirements for a type of biopharmaceutical product starting clinical trials and clinical trial supplies strategy needs to be continuously improved. The growth of the global clinical trials supplies market is attributed to key driving factors such as increasing R&D expenditures in the pharmaceutical & biopharmaceutical companies, increase in the number of clinical trials, and higher costs of drug development in developed nations. However, the rising cost of drug development and clinical trials and challenges for clinical trials due to the coronavirus's negative impact is expected to restrain the market growth during the forecast years.
Growth Drivers and Challenges:
The growing healthcare sector in developing countries of Asia-Pacific creates better opportunities for the clinical trial supplies management market players to expand their business. The huge patient population in these countries is generating demand for more clinical trials. More clinical trials are conducted in the Asia Pacific than in the US or Europe. This shift is ascribed to low operational costs, large patient recruitment potential, contract research organization's growth, favorable regulatory environment, and better clinical trial capacity and quality. In developed regions such as North America and Europe, ~35% of trials are delayed due to problems in patient recruitment, and one-fifth of the trials are refrained from enrollment due to insufficient subjects. As per the report “Clinical Trials in Asia: A World Health Organization database study,” from 2008 to 2017, the average yearly rise in the number of clinical trials conducted was 41.9% in Iran, 27.1% in Sri Lanka, 23.3% in China, 21.3% in India, 18.4% in Japan, 14.7% in Thailand, 8.4% in Malaysia, and 12.9% in Korea.
The high incidence of chronic diseases in Asia is a key factor likely to contribute to the surge in the number of clinical trials in Asia. According to the World Health Organization (WHO), non-communicable diseases cause 55% of the total deaths, ~8 million every year, in the region. In addition, pharmaceutical companies are likely to conduct drug trials for treating gastroesophageal or liver cancer in China or Korea, respectively, as these countries have many patients suffering from these diseases. Moreover, clinical trials in Asia cost ~30–40% lower than in the US and the EU as the doctor visits and medical treatments and procedures are less pricey in Asian countries.
Moreover, the major players in the market, such as Catalent, Inc., Thermo Fisher Scientific, Inc., Almac Group, Parexel International Corporation, Biocair, UDG Healthcare plc (Sharp), PCI Healthcare Services, Owens & Minor Inc., KLIFO, Rubicon Research Pvt. Ltd., CLINICAL SUPPLIES MANAGEMENT HOLDINGS, INC. are anticipated to provide significant growth opportunities to the players operating in the worldwide clinical trials supply market during the forecasted period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Clinical Trial Supplies Market: Strategic Insights
Market Size Value in US$ 1,867.44 Million in 2019 Market Size Value by US$ 3,298.91 Million by 2027 Growth rate CAGR of 7.4% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Clinical Trial Supplies Market: Strategic Insights
| Market Size Value in | US$ 1,867.44 Million in 2019 |
| Market Size Value by | US$ 3,298.91 Million by 2027 |
| Growth rate | CAGR of 7.4% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The “Global Clinical Trials Supplies Market” is segmented based on product & services, stage, drug type, application, and geography. Based on products & services, the market is segmented into manufacturing, packaging & labeling, and logistics & distribution. Based on stage, the clinical trial supplies market is segmented into phase I, II, III, and bioequivalence studies. The clinical trial supplies market is segmented into small-molecule and biological drugs based on drug type. Based on application, the clinical trial supplies market has been segmented into oncology, cardiovascular diseases, neurological disorders, respiratory disorders, and others. The clinical trials supply market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Segmental Analysis:
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Based on products & services, the market is segmented into manufacturing, packaging & labeling, and logistics & distribution. The logistics & distribution segment held the largest share of the market in 2019; the segment is anticipated to register the highest CAGR in the market during the forecast period. The logistics and distribution segment is estimated to be the largest segment by product and service, owing to the rising contract manufacturing in the pharmaceutical industry. The cost required for the clinical trial process is much higher. Pharmaceutical and biopharmaceutical companies invest a lot in strict handling of pharmaceutical operations during clinical trials. Thus, various pharmaceutical companies outsource their clinical trials to avoid the unnecessary handling cost due to overproduction, oversupply, and inventory expiration. Thus, the factors are responsible for the growth of the clinical trials supply & logistics market.
Outsourcing clinical trials to contract manufacturers and service providers provides sufficient time to develop other drug formulations, maintain frequent and constant communication with pharmaceutical companies, and prevent risks and other benefits. Companies such as Fisher Clinical Services, Inc., PAREXEL International, and Piramal Pharma Solutions offer logistics and distribution services to pharmaceutical and biopharmaceutical companies. Thus, the factors mentioned above are responsible for the growth of the clinical trial supply market size.
Clinical Trials Supplies Market, by Product – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Based on stage, the clinical trial supplies market is segmented into phase I, phase II, phase III, and bioequivalence studies. The Phase III segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period. Phase III clinical trial stage is done for large patient groups. The phase III clinical trial stage assist in determining the short-term and long-term efficacy of the active pharmaceutical ingredients. Thus, the assessment is done for the formulated drug's total and associated therapeutic values. As many patients are involved in the clinical trials of phase III, it is important to maintain the efficacy, safety, and accuracy of the drug, which otherwise may result in adverse effects of the drugs in many patients registered for the phase III clinical trials. Shertech Manufacturing is one such company that offers phase III clinical trial services, and it offers comprehensive, definitive data related to efficacy and side effects to its customers. It also assists in complying with FDA standards that further assist in introducing the drug into the market and completing the required licensing applications. Thus, pain management contributes to the clinical trial supplies market and is expected to continue the trend during the forecast period. 
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Regional Analysis:
Based on geography, the clinical trials supplies market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. The North America, clinical trials supplies market has been analyzed based on three major countries — the US, Canada, and Mexico. The US clinical trials supply market is estimated to hold the largest clinical trials supplies market share during the forecast period. The US's clinical trial supplies market growth is attributed to the presence of market players in the region that offer manufacturing, storage, logistics, and other services, which is likely to enhance the market growth in the country. For instance, Alderley Analytical, Almac, and others are well-known manufacturing organizations offering a wide range of integrated services to more than 600 pharmaceutical and biotech companies. Additionally, the rise in demand for services and medicines in areas of orphan and rare diseases is expected to encourage drug manufacturers to develop smart medicines and recruit patients for clinical trials. The increasing urge for the development of new drugs in the country is also expected to increase the number of industry entrants by keeping up to the fast pace of the pharmaceutical industry.
The UK is the second leading region in the global clinical trials supplies market. Germany holds the largest share in the Europe clinical trials supplies market during the forecast period due to the factors such as the increasing geriatric population and demand for the development of new drugs for various disease types, which has increased the demand for pharmaceutical industries to invest in the R&D for the development of new innovative drugs into the market in the UK.
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global clinical trials supplies market are listed below:
- In May 2020, Sharp, part of UDG Healthcare, purchased a pharmaceutical packaging facility from Quality Packaging Specialists International (QPSI) in the US. Situated in Macungie of, Pennsylvania, the 160,000ft² facility provides primary and secondary pharmaceutical packaging services to its customers. The Macungie facility provides bottling, blistering, vial labeling, medical device kitting, and sterlization services
- In April 2021, Catalent added cryogenic capabilities at its Philadelphia clinical supply services facility. This expansion helped increase Catalent's capabilities in gene therapies, packaging, labeling, and distribution of cryogenic materials for clinical trials.
Competitive Landscape and Key Companies:
Some of the prominent players operating in the clinical trials supply market are Catalent, Inc., Thermo Fisher Scientific, Inc., Almac Group, Parexel International Corporation, Biocair, UDG Healthcare plc (Sharp), PCI Healthcare Services, Owens & Minor Inc., KLIFO, Rubicon Research Pvt. Ltd., CLINICAL SUPPLIES MANAGEMENT HOLDINGS, INC. among others are the leading companies operating in the clinical trials supplies market. These companies focus on various growth strategies such as collaboration, product launches, business expansions, and agreements to retain their position in the global market. Their widespread global presence allows them to serve a large set of customers and subsequently increases their clinical trials supplies market share.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product & Service ; Stage ; Drug Type ; Application , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Increasing pharmaceutical and biopharmaceutical R&D expenditures and an increase in the number of clinical trials. Additionally, the future trend, such as growing biosimilars and biologics market, is likely to increase the growth of the clinical trial supplies in the forecasted period.
The rising cost of drug development and clinical trials and challenges for clinical trials due to adverse impact of coronavirus are some of the major factors hampering the market growth.
The clinical trial is an investigation study that defines whether a medical approach, therapy, or device is effective, safe, and useful for human applications. These studies help to find which therapeutic approaches experiment is best for certain diseases. Clinical trial supplies management is necessary for evading overproduction, oversupply, and inventory expiration. With the increasing costs of drug discovery, clinical trial supplies are obtaining more importance. Also, the implementation of more stringent handling requirements for a type of biopharmaceutical products starting clinical trials, clinical trial supplies strategy needs to be continuously improved.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Clinical Trial Supplies Market – By Product & Service
1.3.2 Global Clinical Trial Supplies Market – By Stage
1.3.3 Global Clinical Trial Supplies Market – By Drug Type
1.3.4 Global Clinical Trial Supplies Market – By Application
1.3.5 Global Clinical Trial Supplies Market – By Geography
2. Clinical Trial Supplies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Clinical Trial Supplies – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America – PEST Analysis
4.3 Expert Opinion
5. Clinical Trial Supplies – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Pharmaceutical and Biopharmaceutical R&D Expenditures
5.1.2 Increase in Number of Clinical Trials
5.2 Market Restraints
5.2.1 Rising Cost of Drug Development and Clinical Trials
5.2.2 Challenges for Clinical Trials Due to Negative Impact of Corona Virus
5.3 Key Market Opportunities
5.3.1 Growing Opportunities in Developing Nations
5.4 Future Trends
5.4.1 Growing Biosimilars and Biologics Market
5.5 Impact analysis
6. Clinical Trial Supplies Market – Global Analysis
6.1 Global Clinical Trial Supplies Market Revenue Forecast And Analysis
6.2 Global Clinical Trial Supplies Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
6.3.1 Catalent, Inc.
6.3.2 Thermo Fisher Scientific, Inc.
7. Clinical Trial Supplies Market Analysis – By Product and Service
7.1 Overview
7.2 Clinical Trial Supplies Market Revenue Share, by Product and Service (2019 and 2027)
7.3 Logistics & Distribution
7.3.1 Overview
7.3.2 Logistics & Distribution: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Manufacturing
7.4.1 Overview
7.4.2 Manufacturing: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Packaging & Labelling
7.5.1 Overview
7.5.2 Packaging & Labelling: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
8. Clinical Trial Supplies Market – By Stage
8.1 Overview
8.2 Clinical Trial Supplies Market, by Stage, 2019 and 2027 (%)
8.3 Phase III
8.3.1 Overview
8.3.2 Phase III: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Phase II
8.4.1 Overview
8.4.2 Phase II: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Bioequivalence Studies
8.5.1 Overview
8.5.2 Bioequivalence Studies: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Phase I
8.6.1 Overview
8.6.2 Phase I: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
9. Clinical Trial Supplies Market – By Drug Type
9.1 Overview
9.2 Clinical Trial Supplies Market, by Drug Type 2019 and 2027 (%)
9.3 Small-molecule Drugs
9.3.1 Overview
9.3.2 Small-molecule Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Biologic Drugs
9.4.1 Overview
9.4.2 Biologic Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
10. Clinical Trial Supplies Market – By Application
10.1 Overview
10.2 Clinical Trial Supplies Market, by Application 2019 and 2027 (%)
10.3 Oncology
10.3.1 Overview
10.3.2 Oncology: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
10.4 Cardiovascular Diseases
10.4.1 Overview
10.4.2 Cardiovascular Diseases: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
10.5 Neurological Disorders
10.5.1 Overview
10.5.2 Neurological Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
10.6 Respiratory Disorders
10.6.1 Overview
10.6.2 Respiratory Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
11. Clinical Trial Supplies Market – Geographic Analysis
11.1 North America: Clinical Trial Supplies Market
11.1.1 Overview
11.1.2 North America: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.1.4 North America: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.1.5 North America: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.1.6 North America: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.1.7 North America: Clinical Trial Supplies Market, by Country, 2019 & 2027 (%)
11.1.8 US: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.1.8.3 US: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.1.8.4 US: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.1.8.5 US: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.1.9 Canada: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.1.9.3 Canada: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.1.9.4 Canada: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.1.9.5 Canada: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.1.10 Mexico: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.1.10.3 Mexico: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.1.10.4 Mexico: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.1.10.5 Mexico: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.2 Europe: Clinical Trial Supplies Market
11.2.1 Overview
11.2.2 Europe: Clinical Trial Supplies Market - Revenue and Forecast to 2027 (USD Million)
11.2.3 Europe: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.2.4 Europe: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.2.5 Europe: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.2.6 Europe: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.2.7 Europe: Clinical Trial Supplies Market, by Country, 2018 & 2027 (%)
11.2.8 Germany: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.2.8.1 Germany: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.2.8.2 Germany: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.2.8.3 Germany: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.2.8.4 Germany: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.2.8.5 Germany: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.2.9 UK: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.2.9.1 UK: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.2.9.2 UK: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.2.9.3 UK: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.2.9.4 UK: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.2.9.5 UK: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.2.10 France: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.2.10.1 France: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.2.10.2 France: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.2.10.3 France: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.2.10.4 France: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.2.10.5 France: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.2.11 Spain: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.2.11.1 Spain: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.2.11.2 Spain: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.2.11.3 Spain: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.2.11.4 Spain: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.2.11.5 Spain: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.2.12 Italy: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.2.12.1 Italy: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.2.12.2 Italy: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.2.12.3 Italy: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.2.12.4 Italy: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.2.12.5 Italy: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.3 Asia Pacific: Clinical Trial Supplies Market
11.3.1 Overview
11.3.2 Asia Pacific: Clinical Trial Supplies Market - Revenue and Forecast to 2027 (USD Million)
11.3.3 Asia Pacific: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.3.4 Asia Pacific: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.3.5 Asia Pacific: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.3.6 Asia Pacific: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.3.7 Asia Pacific: Clinical Trial Supplies Market, by Country, 2018 & 2027 (%)
11.3.8 China: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.3.8.1 China: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.3.8.2 China: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.3.8.3 China: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.3.8.4 China: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.3.8.5 China: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.3.9 Japan: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.3.9.1 Japan: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.3.9.2 Japan: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.3.9.3 Japan: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.3.9.4 Japan: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.3.9.5 Japan: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.3.10 India: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.3.11 India: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.3.11.1 India: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.3.11.2 India: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.3.11.3 India: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.3.11.4 India: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.3.12 South Korea: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.3.12.1 South Korea: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.3.12.2 South Korea: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.3.12.3 South Korea: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.3.12.4 South Korea: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.3.12.5 South Korea: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.3.13 Australia: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.3.13.1 Australia: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.3.13.2 Australia: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.3.13.3 Australia: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.3.13.4 Australia: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.3.13.5 Australia: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.4 Middle East & Africa: Clinical Trial Supplies Market
11.4.1 Overview
11.4.2 Middle East & Africa: Clinical Trial Supplies Market - Revenue and Forecast to 2027 (USD Million)
11.4.3 Middle East & Africa: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.4.4 Middle East & Africa: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.4.5 Middle East & Africa: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.4.6 Middle East & Africa: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.4.7 Middle East & Africa: Clinical Trial Supplies Market Share by Country – 2019 & 2027, (%)
11.4.8 Saudi Arabia: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.4.8.1 Saudi Arabia: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.4.8.2 Saudi Arabia: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.4.8.3 Saudi Arabia: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.4.8.4 Saudi Arabia: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.4.8.5 Saudi Arabia: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.4.9 UAE: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.4.9.1 UAE: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.4.9.2 UAE: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.4.9.3 UAE: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.4.9.4 UAE: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.4.9.5 UAE: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.4.10 South Africa: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
11.4.10.1 South Africa: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.4.10.2 South Africa: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.4.10.3 South Africa: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.4.10.4 South Africa: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.4.10.5 South Africa: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.5 South and Central America: Clinical Trial Supplies Market
11.5.1 Overview
11.5.2 South and Central America: Clinical Trial Supplies Market - Revenue and Forecast to 2027 (US$ Million)
11.5.3 South and Central America: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.5.4 South and Central America: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.5.5 South and Central America: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.5.6 South and Central America: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.5.7 South and Central America: Clinical Trial Supplies Market, by Country, 2018 & 2027 (%)
11.5.8 Brazil: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.5.8.1 Brazil: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.5.8.2 Brazil: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.5.8.3 Brazil: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.5.8.4 Brazil: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.5.8.5 Brazil: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.5.9 Argentina: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.5.9.1 Argentina: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.5.9.2 Argentina: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.5.9.3 Argentina: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.5.9.4 Argentina: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.5.9.5 Argentina: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
12. Impact Of COVID-19 Pandemic On Global Clinical Trial Supplies Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
13. Clinical Trial Supplies Market – Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Clinical Trial Supplies Market – Key Company Profiles
14.1 THERMO FISHER SCIENTIFIC INC.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 UDG Healthcare plc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Catalent Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 pci Pharma Services
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Almac Group
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 PAREXEL INTERNATIONAL CORPORATION
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Biocair
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Owens & Minor Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 KLIFO
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Rubicon Research Pvt. Ltd.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. R&D Investments by Major Pharmaceuticals Companies
Table 2. R&D Investments by PhRMA Member Companies,2018
Table 3. R&D Investments of PhRMA Member Companies, by Trial Stage, 2018
Table 4. Medicines In Development For Non-Communicable Diseases (NCDS)
Table 5. Number of Registered Studies for Clinical Trials
Table 6. North America Clinical Trial Supplies Market, by Product & Service– Revenue and Forecast to 2027 (USD Million)
Table 7. North America Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 8. North America Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 9. North America Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 10. US Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 11. US Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 12. US Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 13. US Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 14. Canada Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 15. Canada Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 16. Canada Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 17. Canada Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 18. Mexico Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 19. Mexico Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 20. Mexico Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 21. Mexico Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 22. Europe Clinical Trial Supplies Market, by Product & Service– Revenue and Forecast to 2027 (USD Million)
Table 23. Europe Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 24. Europe Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 25. Europe Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 26. Germany Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 27. Germany Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 28. Germany Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 29. Germany Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 30. UK Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 31. UK Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 32. UK Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 33. UK Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 34. France Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 35. France Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 36. France Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 37. France Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 38. Spain Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 39. Spain Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 40. Spain Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 41. Spain Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 42. Italy Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 43. Italy Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 44. Italy Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 45. Italy Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 46. Asia Pacific Clinical Trial Supplies Market, by Product & Service– Revenue and Forecast to 2027 (USD Million)
Table 47. Asia Pacific Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 48. Asia Pacific Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 49. Asia Pacific Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 50. China: Major global pharmaceutical companies by R&D investments, 2013`
Table 51. China Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 52. China Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 53. China Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 54. China Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 55. Japan Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 56. Japan Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 57. Japan Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 58. Japan Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 59. India: R&D spending of Pharmaceutical companies (2010 & 2017)
Table 60. India Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 61. India Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 62. India Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 63. India Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 64. South Korea Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 65. South Korea Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 66. South Korea Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 67. South Korea Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 68. Australia Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 69. Australia Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 70. Australia Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 71. Australia Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 72. Middle East & Africa Clinical Trial Supplies Market, by Product & Service– Revenue and Forecast to 2027 (USD Million)
Table 73. Middle East & Africa Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 74. Middle East & Africa Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 75. Middle East & Africa Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 76. Saudi Arabia Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 77. Saudi Arabia Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 78. Saudi Arabia Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 79. Saudi Arabia Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 80. UAE Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 81. UAE Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 82. UAE Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 83. UAE Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 84. South Africa Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 85. South Africa Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 86. South Africa Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 87. South Africa Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 88. South and Central America Clinical Trial Supplies Market, by Product & Service– Revenue and Forecast to 2027 (USD Million)
Table 89. South and Central America Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 90. South and Central America Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 91. South and Central America Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 92. Brazil Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 93. Brazil Clinical Trials Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 94. Brazil Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 95. Brazil Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 96. Argentina Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 97. Argentina Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 98. Argentina Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 99. Argentina Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 100. Organic Developments Done By Companies
Table 101. Inorganic Developments Done By Companies
Table 102. Glossary of Terms, Clinical Trial Supplies Market
LIST OF FIGURES
Figure 1. Clinical Trial Supplies Market Segmentation
Figure 2. Clinical Trial Supplies Segmentation, By Region
Figure 3. Global Clinical Trial Supplies Market Overview
Figure 4. Logistics & Distribution Segment Held Largest Share Of Product & Service Segment In Clinical Trial Supplies Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Clinical Trial Supplies Market, By Geography (US$ Million)
Figure 7. Global Clinical Trial Supplies Market- Leading Country Markets (US$ Million)
Figure 8. Global Clinical Trial Supplies Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South And Central America PEST Analysis
Figure 14. Number of approvals for NDA & BLA (2005 to 2016)
Figure 15. Clinical Trial Supplies Market Impact Analysis of Drivers and Restraints
Figure 16. Global Clinical Trial Supplies Market – Revenue Forecast And Analysis – 2019- 2027
Figure 17. Global Clinical Trial Supplies Market – By Geography Forecast And Analysis – 2019- 2027
Figure 18. Market Positioning Of Key Players In Global Clinical Trial Supplies Market
Figure 19. Clinical Trial Supplies Market Revenue Share, by Product and Service (2019 and 2027)
Figure 20. Logistics & Distribution: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Manufacturing: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Packaging & Labelling: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Clinical Trial Supplies Market, by Stage 2019 and 2027 (%)
Figure 24. Phase III: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Phase II: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Bioequivalence Studies: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Phase I: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Clinical Trial Supplies Market, by Drug Type, 2019 and 2027 (%)
Figure 29. Small-molecule Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. Biologics Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Clinical Trial Supplies Market, by Application, 2019 and 2027 (%)
Figure 32. Oncology: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. Cardiovascular Diseases: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 34. Neurological Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 35. Respiratory Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 36. Others: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 37. North America: Clinical Trial Supplies Market, by Key Country – Revenue (2019) (USD Million)
Figure 38. North America Clinical Trial Supplies Market Revenue and Forecast to 2027 (USD Million)
Figure 39. North America: Clinical Trial Supplies Market, by Country, 2019 & 2027 (%)
Figure 40. US: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 41. Canada: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 42. Mexico: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. Europe: Clinical Trial Supplies Market, by Key Country – Revenue (2019) (USD Million)
Figure 44. Europe Clinical Trial Supplies Market Revenue and Forecast to 2027 (USD Million)
Figure 45. Europe: Clinical Trial Supplies Market, by Country, 2018 & 2027 (%)
Figure 46. Germany: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 47. UK: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 48. France: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. Spain: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 50. Italy: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. Asia Pacific: Clinical Trial Supplies Market, by Key Country – Revenue (2019) (USD Million)
Figure 52. Asia Pacific Clinical Trial Supplies Market Revenue and Forecast to 2027 (USD Million)
Figure 53. China: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 54. Japan: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 55. India: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 56. South Korea: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 57. Australia: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 58. Middle East & Africa: Clinical Trial Supplies Market, by Key Country – Revenue (2019) (USD Million)
Figure 59. Middle East & Africa Clinical Trial Supplies Market Revenue and Forecast to 2027 (USD Million)
Figure 60. Middle East & Africa: Clinical Trial Supplies Market Share by Country – 2019 & 2027, (%)
Figure 61. Saudi Arabia: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 62. UAE: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 63. South Africa: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 64. South and Central America: Clinical Trial Supplies Market, by Key Country – Revenue (2019) (USD Million)
Figure 65. South and Central America Clinical Trial Supplies Market Revenue and Forecast to 2027 (USD Million)
Figure 66. South and Central America: Clinical Trial Supplies Market, by Country, 2018 & 2027 (%)
Figure 67. Brazil: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 68. Argentina: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 69. Impact of COVID-19 Pandemic In North American Country Markets
Figure 70. Impact of COVID-19 Pandemic In European Country Markets
Figure 71. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
Figure 72. Impact Of COVID-19 Pandemic In Rest of the World Market
Figure 73. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Clinical Trial Supplies Market
- Catalent, Inc.
- Thermo Fisher Scientific, Inc.
- Almac Group
- Parexel International Corporation
- Biocair
- UDG Healthcare plc (Sharp)
- PCI Healthcare Services
- Owens & Minor Inc.
- KLIFO
- Rubicon Research Pvt. Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Clinical Trial Supplies Market
Mar 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Mar 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Mar 2020
Drug Delivery Market
Forecast to 2028 - Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)